Skip to main content
Log in

Bimatoprost/timolol of value for glaucoma in Europe

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Hommer A, Wickstrøm J, Friis MM, Steeds C, Thygesen J, Ferreras A, Gouws P, Buchholz P.A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective. Current Medical Research and Opinion 24: 1057-1063, No. 4, Apr 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bimatoprost/timolol of value for glaucoma in Europe. Pharmacoecon. Outcomes News 551, 5 (2008). https://doi.org/10.2165/00151234-200805510-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805510-00011

Keywords

Navigation